
    
      This study consisted of 2 sequential phases: Screening/Eligibility Phase, followed by a
      Masked Treatment Phase (Phase II). Subjects were assigned into one of 3 PGA therapy groups
      for the duration of the study, based upon commercial availability.
    
  